Laurus Labs announced that its subsidiary, Laurus Bio, has signed a definitive agreement for an equity investment of Rs 120 crore from Eight Roads Ventures and F-Prime Capital. Laurus Labs also agreed to co-invest an additional Rs 40 crore at the same valuation. The Promoters of Laurus Bio have also been issued share warrants, exercisable up to two years from the date of issue at the same valuation.
Laurus Labs or Eight Roads Ventures have the right to invest up to an additional amount of Rs 35 crore before Dec 2025 at the same valuation. Upon completion of the transaction, the Company, Eight Roads Ventures and the Promoters of Laurus Bio will hold 75%, 14% and 9% stake respectively on a fully diluted basis. The Company will utilize the equity infusion for further expansion of its fermentation-based manufacturing capabilities in order to cater to growing customer demand.
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
 "CEAT")
 "Ashwini Vaishnaw, Ashwini, Vaishnaw")
 "Commerce and Industry Minister Piyush Goyal")
 "ipo market listing share market")
 "Trinamool Congress (TMC) MP Saket Gokhale speaks in the Rajya Sabha during the Interim Budget Session of the Parliament, in New Delhi on Tuesday")
